about
The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?The epidemiology of pulmonary nontuberculous mycobacteria: data from a general hospital in Athens, Greece, 2007-2013.The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD.Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)Quantitative computed tomography: what does airway obstruction look-like?Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.Prevalence and determinants of current and secondhand smoking in Greece: results from the Global Adult Tobacco Survey (GATS) studyPulmonary biomarkers in COPD exacerbations: a systematic review.The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.Serum periostin in patients hospitalized for COPD exacerbations.A European Respiratory Society technical standard: exhaled biomarkers in lung disease.Prediction and prevention of exacerbations and mortality in patients with COPD.Predictors of future exacerbation risk in patients with asthma.Duration of Hospitalization and Lung Function Deterioration as Predictors of Future Chronic Obstructive Pulmonary Disease Exacerbations.Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.The role of endosomal toll-like receptors in asthma.Adrenomedullin optimises mortality prediction in COPD patients.How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?Prevalence of lung function impairment among Greek cement production workers: a cross-sectional study.Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD.Prognostic assessment in COPD without lung function: the B-AE-D indices.Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial.Collateral damage: depressive symptoms in the partners of COPD patients.Serum angiopoietin-2 and CRP levels during COPD exacerbations.Exhaled breath temperature in optimally treated asthmatics: severity and underlying mechanisms.Changes in BODE Quartiles After Pulmonary Rehabilitation Do Not Predict 2-Year Survival in Patients With COPD.Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program.Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits.Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes.The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics."Education is the passport to the future": enabling today's medical teachers to prepare tomorrow's respiratory health practitioners.Prevalence of sleep-related symptoms in a primary care population - their relation to asthma and COPD.Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD.At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin.Activin A and follistatin in patients with asthma. Does severity make the difference?
P50
Q26745760-A685E9C7-953B-49BE-944F-3D0F84D98868Q30843389-5D8C29EC-EFBA-4F08-B6DC-C617D5632229Q33649840-BE70660F-C50B-4213-888E-F63CBAFD451CQ36060275-A6C5015D-213E-4CFD-BC1C-12F254EBAD6BQ36329064-49BFD647-540E-4BCE-8DB4-BAE8BFBEE998Q37069374-65ABB521-6E23-4B68-9445-747EBE7E1043Q37329525-418B9712-6EF7-42B4-836A-A70368A53E87Q37578975-EA6F335D-9DAD-4058-8C92-622BE20285F8Q37598274-3FED4219-A18A-4261-A407-B6ED4CD2E0BBQ38154291-04383C22-FAFF-43DE-B1F1-9C27CC105E42Q38597502-01CE0A2E-81CE-4CF2-B190-36D7D74DFEA0Q38683014-962FA0CF-4EE9-4D84-8348-5278D84433D8Q38690466-A52713FD-D4B8-4EDD-9952-B34C440CC993Q38823010-B867DDEB-0306-4673-9D50-908EEC158956Q38834113-ED911DD4-C5CD-435D-A5D3-289143A2EBE2Q38895033-E2494349-6504-47A2-AF09-5D5919003D20Q38919001-0A89E464-0623-4078-B313-97D7444061A5Q38965992-AF19C9C7-01A0-4547-86A3-415A06D16C09Q39011404-6B20F4F6-9DFB-4B9D-B971-7B36244CA9F1Q39030602-1610EB4C-F0A5-4D55-81A5-C6A9DB6C76C4Q40072889-E0829557-3D99-4349-BC34-2644FD97FCEBQ40602171-5CB2D55F-0D15-4AF0-8D84-1270FBD9099FQ40786706-41B3C279-663D-4EA8-81B2-022A59A95393Q41054096-7BBAA6EC-E026-49DB-831A-CBE71EA01E56Q45047008-731C6B42-39AC-4F64-A1BF-318240C72BE1Q45908560-F68FC998-04AA-47C4-B9D9-3E0EE0D8DD60Q47313728-56A6CE46-D400-4C6B-9DE5-086D2A542061Q47613067-781B5402-EEDF-4E4B-8C1E-DD881C0F709FQ47724396-52B748DA-EF53-49DD-AFD1-84CAF6EBEE77Q47737129-AC68089C-02E8-4360-B671-A09CA4E91773Q47880066-A7F60E80-E590-4761-B8D5-41D4BDE403B5Q47920475-32A9A092-1859-4C19-BE10-2C3CD4AB61F6Q47923680-CD5DA79B-4C2B-49B8-B84B-A381AFD35BB9Q48033438-2D0A4026-FADB-4D3D-9037-8EFB1AC260E4Q48461366-2138AC36-D3C3-4BC6-AF37-6C0CEB2684E7Q49992860-45B03DD2-9FB5-4A0F-B0F0-204246D8B245Q50046297-58EBEA24-7801-4A6D-9FAC-E0147DF8CC2CQ50181533-09236DB4-467F-419B-AB77-C7772F2200FBQ51244071-10F20E8F-17CA-4208-A115-97B7E42B7517Q51347768-8AEBCAA2-751A-49A8-9FC3-5F4BC9FE6724
P50
description
researcher ORCID ID = 0000-0003-0774-3942
@en
wetenschapper
@nl
name
Konstantinos Kostikas
@ast
Konstantinos Kostikas
@en
Konstantinos Kostikas
@es
Konstantinos Kostikas
@nl
type
label
Konstantinos Kostikas
@ast
Konstantinos Kostikas
@en
Konstantinos Kostikas
@es
Konstantinos Kostikas
@nl
prefLabel
Konstantinos Kostikas
@ast
Konstantinos Kostikas
@en
Konstantinos Kostikas
@es
Konstantinos Kostikas
@nl
P106
P31
P496
0000-0003-0774-3942